R&D BIOPHARMACEUTICALS GMBH
Patent Applications and Registrations
Patent applications and USPTO patent grants for R&D BIOPHARMACEUTICALS GMBH.The latest application filed is for "tubulin inhibitors".
- R&D BIOPHARMACEUTICALS GMBH - Martinsreid DE
- R&D-Biopharmaceuticals GmbH - Martinsried DE
- R & D Biopharmaceuticals GmbH -
| Patent | Date |
|---|---|
| Tubulin inhibitors Grant 9,163,060 - Richter October 20, 2 | 2015-10-20 |
| Tubulysine derivatives Grant 8,980,833 - Richter March 17, 2 | 2015-03-17 |
| Tubulin inhibitors Grant 8,772,244 - Richter July 8, 2 | 2014-07-08 |
| Tubulin Inhibitors App 20120252738 - Richter; Wolfgang | 2012-10-04 |
| Tubulin Inhibitors App 20120252739 - Richter; Wolfgang | 2012-10-04 |
| Tubulysine Derivatives App 20120129779 - Richter; Wolfgang | 2012-05-24 |
| Tubulysin analogues Grant 7,816,377 - Domling , et al. October 19, 2 | 2010-10-19 |
| Macrocycles for the treatment of cancer Grant 7,807,710 - Richter , et al. October 5, 2 | 2010-10-05 |
| Tubulysin conjugates Grant 7,776,814 - Domling , et al. August 17, 2 | 2010-08-17 |
| Tubulysin conjugates App 20050249740 - Domling, Alexander ; et al. | 2005-11-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 